
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
NETs: organ-related epigenetic derangements and potential clinical applications
Mauro Cives, Valeria De Simone, Francesca Rizzo, et al.
Oncotarget (2016) Vol. 7, Iss. 35, pp. 57414-57429
Open Access | Times Cited: 25
Mauro Cives, Valeria De Simone, Francesca Rizzo, et al.
Oncotarget (2016) Vol. 7, Iss. 35, pp. 57414-57429
Open Access | Times Cited: 25
Showing 25 citing articles:
Pan-cancer whole-genome analyses of metastatic solid tumours
Peter Priestley, Jonathan Baber, Martijn P. Lolkema, et al.
Nature (2019) Vol. 575, Iss. 7781, pp. 210-216
Open Access | Times Cited: 922
Peter Priestley, Jonathan Baber, Martijn P. Lolkema, et al.
Nature (2019) Vol. 575, Iss. 7781, pp. 210-216
Open Access | Times Cited: 922
Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
Inbal Uri, Simona Grozinsky‐Glasberg
Clinical Diabetes and Endocrinology (2018) Vol. 4, Iss. 1
Open Access | Times Cited: 60
Inbal Uri, Simona Grozinsky‐Glasberg
Clinical Diabetes and Endocrinology (2018) Vol. 4, Iss. 1
Open Access | Times Cited: 60
Role of Somatostatin Signalling in Neuroendocrine Tumours
Olesja Rogoza, Kaspars Megnis, Marija Kudrjavceva, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1447-1447
Open Access | Times Cited: 34
Olesja Rogoza, Kaspars Megnis, Marija Kudrjavceva, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1447-1447
Open Access | Times Cited: 34
Molecular Classification and Characterization of Noninsulinoma: Ready for Prime Time in Clinical Practice?
Kaijian Zhang
International Journal of Surgical Pathology (2025)
Closed Access
Kaijian Zhang
International Journal of Surgical Pathology (2025)
Closed Access
Pan-cancer whole genome analyses of metastatic solid tumors
Peter Priestley, Jonathan Baber, Martijn P. Lolkema, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2018)
Open Access | Times Cited: 31
Peter Priestley, Jonathan Baber, Martijn P. Lolkema, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2018)
Open Access | Times Cited: 31
Updates on the Role of Molecular Alterations and NOTCH Signalling in the Development of Neuroendocrine Neoplasms
Claudia von Arx, Monica Capozzi, Elena López‐Jiménez, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 9, pp. 1277-1277
Open Access | Times Cited: 20
Claudia von Arx, Monica Capozzi, Elena López‐Jiménez, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 9, pp. 1277-1277
Open Access | Times Cited: 20
Current and New Challenges in the Management of Pancreatic Neuroendocrine Tumors: The Role of miRNA-Based Approaches as New Reliable Biomarkers
Andrei Havași, Daniel Sur, Simona Căinap, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1109-1109
Open Access | Times Cited: 12
Andrei Havași, Daniel Sur, Simona Căinap, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1109-1109
Open Access | Times Cited: 12
Epigenetic Regulation in Gastroenteropancreatic Neuroendocrine Tumors
Judy S. Crabtree
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Judy S. Crabtree
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Update in the Therapy of Advanced Neuroendocrine Tumors
Inbal Uri, Shani Avniel-Polak, David J. Gross, et al.
Current Treatment Options in Oncology (2017) Vol. 18, Iss. 12
Closed Access | Times Cited: 20
Inbal Uri, Shani Avniel-Polak, David J. Gross, et al.
Current Treatment Options in Oncology (2017) Vol. 18, Iss. 12
Closed Access | Times Cited: 20
Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors
Ornella Franzese, Francesco Torino, Maria Pia Fuggetta, et al.
Oncotarget (2017) Vol. 8, Iss. 25, pp. 41641-41669
Open Access | Times Cited: 19
Ornella Franzese, Francesco Torino, Maria Pia Fuggetta, et al.
Oncotarget (2017) Vol. 8, Iss. 25, pp. 41641-41669
Open Access | Times Cited: 19
Ketogenic diet: a tool for the management of neuroendocrine neoplasms?
Giovanna Muscogiuri, Luigi Barrea, Federica Campolo, et al.
Critical Reviews in Food Science and Nutrition (2020) Vol. 62, Iss. 4, pp. 1035-1045
Closed Access | Times Cited: 17
Giovanna Muscogiuri, Luigi Barrea, Federica Campolo, et al.
Critical Reviews in Food Science and Nutrition (2020) Vol. 62, Iss. 4, pp. 1035-1045
Closed Access | Times Cited: 17
Molecular profile of pancreatic neuroendocrine neoplasms (PanNENs): Opportunities for personalized therapies
Jemma Arakelyan, Davit Zohrabyan, Philip A. Philip
Cancer (2020) Vol. 127, Iss. 3, pp. 345-353
Open Access | Times Cited: 17
Jemma Arakelyan, Davit Zohrabyan, Philip A. Philip
Cancer (2020) Vol. 127, Iss. 3, pp. 345-353
Open Access | Times Cited: 17
WOMEN IN CANCER THEMATIC REVIEW: Systemic therapies in neuroendocrine tumors and novel approaches toward personalized medicine
Marianne Pavel, Christine Sers
Endocrine Related Cancer (2016) Vol. 23, Iss. 11, pp. T135-T154
Open Access | Times Cited: 17
Marianne Pavel, Christine Sers
Endocrine Related Cancer (2016) Vol. 23, Iss. 11, pp. T135-T154
Open Access | Times Cited: 17
Molecular challenges of neuroendocrine tumors (Review)
Parthik Patel, Karina Galoian
Oncology Letters (2017)
Open Access | Times Cited: 16
Parthik Patel, Karina Galoian
Oncology Letters (2017)
Open Access | Times Cited: 16
Open issues on G3 neuroendocrine neoplasms: back to the future
Maria Chiara Zatelli, Elia Guadagno, Erika Messina, et al.
Endocrine Related Cancer (2018) Vol. 25, Iss. 6, pp. R375-R384
Open Access | Times Cited: 16
Maria Chiara Zatelli, Elia Guadagno, Erika Messina, et al.
Endocrine Related Cancer (2018) Vol. 25, Iss. 6, pp. R375-R384
Open Access | Times Cited: 16
Perspectives on the diagnostic, predictive and prognostic markers of neuroendocrine neoplasms (Review)
Oana Ciobanu, Sorina Martin, Simona Fica
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 6
Open Access | Times Cited: 12
Oana Ciobanu, Sorina Martin, Simona Fica
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 6
Open Access | Times Cited: 12
Belimumab Decreases Autophagy and Citrullination in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus
Tania Colasanti, Francesca Romana Spinelli, Cristiana Barbati, et al.
Cells (2022) Vol. 11, Iss. 2, pp. 262-262
Open Access | Times Cited: 9
Tania Colasanti, Francesca Romana Spinelli, Cristiana Barbati, et al.
Cells (2022) Vol. 11, Iss. 2, pp. 262-262
Open Access | Times Cited: 9
Clinical and Preclinical Advances in Gastroenteropancreatic Neuroendocrine Tumor Therapy
Judy S. Crabtree
Frontiers in Endocrinology (2017) Vol. 8
Open Access | Times Cited: 14
Judy S. Crabtree
Frontiers in Endocrinology (2017) Vol. 8
Open Access | Times Cited: 14
Insights into Epigenetic Changes Related to Genetic Variants and Cells-of-Origin of Pancreatic Neuroendocrine Tumors: An Algorithm for Practical Workup
Oana Ciobanu, Sorina Martin, Vlad Herlea, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4444-4444
Open Access | Times Cited: 8
Oana Ciobanu, Sorina Martin, Vlad Herlea, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4444-4444
Open Access | Times Cited: 8
Antineoplastic effects of histone deacetylase inhibitors in neuroendocrine cancer cells are mediated through transcriptional regulation of Notch1 by activator protein 1
Samuel Jang, Haining Jin, Madhuchhanda Roy, et al.
Cancer Medicine (2017) Vol. 6, Iss. 9, pp. 2142-2152
Open Access | Times Cited: 10
Samuel Jang, Haining Jin, Madhuchhanda Roy, et al.
Cancer Medicine (2017) Vol. 6, Iss. 9, pp. 2142-2152
Open Access | Times Cited: 10
Transformation of a non-secretory neuroendocrine tumor to insulinoma after treatment with Sunitinib: A case report and review of the literature
Todd Clover, Amrou Abdelkader, Guru Subramanian Guru Murthy
Journal of Oncology Pharmacy Practice (2018) Vol. 25, Iss. 6, pp. 1516-1519
Closed Access | Times Cited: 8
Todd Clover, Amrou Abdelkader, Guru Subramanian Guru Murthy
Journal of Oncology Pharmacy Practice (2018) Vol. 25, Iss. 6, pp. 1516-1519
Closed Access | Times Cited: 8
Loss of ATRX expression predicts worse prognosis in pulmonary carcinoid tumors
Simone Terra, Hao Xie, Jennifer M. Boland, et al.
Human Pathology (2019) Vol. 94, pp. 78-85
Closed Access | Times Cited: 6
Simone Terra, Hao Xie, Jennifer M. Boland, et al.
Human Pathology (2019) Vol. 94, pp. 78-85
Closed Access | Times Cited: 6
MicroRNAs regulatory networks governing the epigenetic landscape of MEN1 gastro‐entero‐pancreatic neuroendocrine tumor: A case report
Ettore Luzi, Luca Pandolfini, Simone Ciuffi, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 4
Open Access | Times Cited: 5
Ettore Luzi, Luca Pandolfini, Simone Ciuffi, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 4
Open Access | Times Cited: 5
Updates on the Role of Molecular Alterations and NOTCH Signaling in the Development of Neuroendocrine Neoplasms
Claudia von Arx, Monica Capozzi, Elena López‐Jiménez, et al.
(2019)
Open Access | Times Cited: 3
Claudia von Arx, Monica Capozzi, Elena López‐Jiménez, et al.
(2019)
Open Access | Times Cited: 3
Management of NETs in the Precision Medicine Era
Mauro Cives, Eleonora Pellè, Franco Silvestris, et al.
Elsevier eBooks (2018), pp. 575-589
Closed Access
Mauro Cives, Eleonora Pellè, Franco Silvestris, et al.
Elsevier eBooks (2018), pp. 575-589
Closed Access